Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vigani

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Chemotherapy (Florence, Italy)|July 21, 1998
A phase II trial of carboplatin, methotrexate and fluorouracil in fluorouracil-pretreated colorectal cancerP Pronzato, F Botto, E Ghio, et al.
Anticancer Research|January 15, 1998
A new schedule for etoposide, epidoxorubicin and cisplatin with granulocyte colony stimulating factor for advanced gastric cancer: a feasibility studyP Pronzato, A Vigani, F Pensa, et al.
Journal of Chemotherapy (Florence, Italy)|May 2, 2001
A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancerA Tognoni, F Pensa, F Vaira, et al.
Minerva Chirurgica|October 31, 1987
[Initial evaluation of a follow-up program in surgically treated colorectal cancer]M Venturini, S Venturini, A Tagliagambe, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|April 1, 1990
[Use of reconstituted basal membranes for the study of invasion of human tumor cells: current status and future prospects]P Visconti, M Percario, A Melchiori, et al.
Anticancer Research|March 1, 1995
Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancerP Pronzato, F Bruna, E Neri, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|June 1, 1990
Effect of recombinant human TNF on human ovarian cancer cell linesA Vigani, L Miglietta, S Chiara, et al.
Journal of Chemotherapy (Florence, Italy)|August 28, 1999
A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non small cell lung cancerA Tognoni, L Cadenotti, F Pensa, et al.
Gynecologic Oncology|April 1, 1991
Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: potentiation of mitoxantrone cytotoxicityA Vigani, S Chiara, L Miglietta, et al.
Minerva Chirurgica|October 31, 1989
[Duodenopancreatectomy with conservation of the pylorus]M Lombardi, R Troiani, E Isoppi, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Chemotherapy (Florence, Italy)|July 21, 1998
A phase II trial of carboplatin, methotrexate and fluorouracil in fluorouracil-pretreated colorectal cancerP Pronzato, F Botto, E Ghio, et al.
Anticancer Research|January 15, 1998
A new schedule for etoposide, epidoxorubicin and cisplatin with granulocyte colony stimulating factor for advanced gastric cancer: a feasibility studyP Pronzato, A Vigani, F Pensa, et al.
Journal of Chemotherapy (Florence, Italy)|May 2, 2001
A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancerA Tognoni, F Pensa, F Vaira, et al.
Minerva Chirurgica|October 31, 1987
[Initial evaluation of a follow-up program in surgically treated colorectal cancer]M Venturini, S Venturini, A Tagliagambe, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|April 1, 1990
[Use of reconstituted basal membranes for the study of invasion of human tumor cells: current status and future prospects]P Visconti, M Percario, A Melchiori, et al.
Anticancer Research|March 1, 1995
Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancerP Pronzato, F Bruna, E Neri, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|June 1, 1990
Effect of recombinant human TNF on human ovarian cancer cell linesA Vigani, L Miglietta, S Chiara, et al.
Journal of Chemotherapy (Florence, Italy)|August 28, 1999
A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non small cell lung cancerA Tognoni, L Cadenotti, F Pensa, et al.
Gynecologic Oncology|April 1, 1991
Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: potentiation of mitoxantrone cytotoxicityA Vigani, S Chiara, L Miglietta, et al.
Minerva Chirurgica|October 31, 1989
[Duodenopancreatectomy with conservation of the pylorus]M Lombardi, R Troiani, E Isoppi, et al.
Pageof 4